Skip to search formSkip to main contentSkip to account menu

KRM 1671

Known as: 25-deacetyl-KRM-1648, KRM-1671, Rifamycin VIII, 25-O-deacetyl-1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-(4-(2-methylpropyl)-1-piperazinyl)-1-oxo- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Rifamycins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
マウス実験的 Mycobacterium avium complex 感染症に対する KRM-1648 の in vivo 治療効果ならびにサイトカイン遺伝子発現に及ぼす接種菌量の影響
1998
1998
Rifalazil(Kaneka corp).
  • M. Pregnolato
  • IDrugs : the investigational drugs journal
  • 1998
  • Corpus ID: 34026765
Rifalazil is a rifamycin derivative from Kaneka that is in phase II clinical trials for the treatment of Mycobacterium… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)